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Abstract 
 The standard technique for percutaneous catheter ablation of atrial fibrillation (AF) 
involves obtaining left atrial access and catheter manipulation from an inferior transfemoral 
venous access. However, in patients with inferior vena cava interruption (IVC-I), a standard 
transfemoral venous approach is not possible. In these cases, a percutaneous approach from a 
superior central vein, such as the internal jugular vein or the axillary/subclavian vein can be 
considered. In this article, we describe the details of our technique to obtain left atrial 
catheterization and perform catheter ablation of AF from a superior approach. Our technique 
involves the use of steerable sheaths, dedicated radiofrequency (RF) wires, and intracardiac 
echocardiography (ICE) guidance. 
Introduction 
 Percutaneous catheter ablation has become an established therapy to control recurrent 
atrial fibrillation (AF), and represents one of the most common invasive procedures performed in 
the electrophysiology laboratory.1 Obtaining left atrial (LA) access is requisite for any AF ablation 
procedure, and is a fundamental skill for the interventional electrophysiologist.2 
 Access to the left heart via atrial transseptal catheterization was first described in 1959 by 
Ross and colleagues as an alternative technique to the conventional transaortic approach to 
obtain left-sided hemodynamic measurements.3, 4 Subsequent technical refinements pioneered 
by Braunwald,5 Brockenbrough,6 and Mullins,7 and significant technological advances have 
further improved the ease and safety of the procedure.8-11 Nevertheless, the general technique for 
transseptal access has remained relatively unchanged over the years, and it involves access 
from an inferior transfemoral venous approach. Only until very recently, all of the available tools 
for transseptal catheterization, including long fixed-curve or deflectable sheaths, dilators, and 












needles/wires have been developed with the specific purpose of facilitating transseptal 
catheterization from the standard inferior transfemoral venous approach. In a small subgroup of 
patients such as those with congenital or acquired inferior vena cava interruption (IVC-I),12, 13 LA 
transseptal catheterization from an inferior approach is not feasible. In these patients, transseptal 
access from a superior venous approach for LA mapping and ablation can be considered. We 
herein describe in detail our approach to LA transseptal catheterization for LA mapping and 
catheter ablation of AF via a superior approach in patients with IVC-I. 
How to Obtain Transseptal Catheterization from a Superior Approach 
Venous Access 
 Proper selection of the superior venous access is important, as it substantially impacts 
the ability to obtain stable contact with the interatrial septum and the facility to advance the 
transseptal sheath into the LA and maintain access during mapping and ablation. In general, two 
venous approaches are used: the right internal jugular vein or the left axillary/subclavian vein.14 
Access is typically performed under ultrasound guidance and every effort is made to puncture the 
vein with a very shallow angle (i.e., 20-30 degrees relative to the long axis of the vein) as this 
greatly improves sheath and catheter manipulation compared to a more perpendicular angle of 
access. The use of ultrasound guidance is also important to minimize the risk of vascular access 
complications, particularly in fully anticoagulated patients. 
 A left axillary/subclavian vein access is usually preferable to improve ergonomics and 
minimize fluoroscopy exposure to the operator (Figure 1). However, in patients with significant 
right atrial (RA) dilatation, achieving stable contact with the interatrial septum from the left 
axillary/subclavian route is more challenging since the body of the transseptal sheath tends to 
drift toward the postero-lateral aspect of the RA, which can be distant from the plane of the 
interatrial septum. Although this limitation can be partially overcome by the use of deflectable 
sheaths with larger curves, maintaining stable LA access from a left axillary/subclavian vein 
approach in patients with an enlarged RA remains difficult. In such cases, it is advisable to use a 
right internal jugular vein approach to increase proximity of the transseptal sheath body with the 
interatrial septum (Figure 1). 












 Obtaining LA catheterization from other superior venous accesses, such as the right 
axillary/subclavian vein or the left internal jugular vein, although theoretically possible, is more 
difficult due to a more acute angle of access to the superior vena cava. Therefore, we have thus 
far employed the right axillary/subclavian vein or the left internal jugular vein only occasionally for 
placement of intracardiac echocardiography (ICE) or other diagnostic catheters (e.g., coronary 
sinus catheter). 
The specific anatomical relationships relevant to the transseptal access are similar to what 
typically encountered with a standard left atrial transseptal catheterization from a femoral venous 
approach (Figure 2, see below). One important aspect that should be emphasized is that, when 
using a superior approach, the operators should be particularly careful to obtain proper venous 
access as the consequences of inadvertent puncture of the adjacent arterial vessels (carotid 
artery or axillary/subclavian artery) can be more serious in fully anticoagulated patients. In this 
regard, we believe that use of ultrasound guidance for access is crucial. 
Intracardiac Echocardiography 
 Direct intraprocedural imaging with ICE is an essential aspect of our technique for AF 
ablation from a superior approach, with a pivotal role in the selection of the ideal transseptal 
access site, validation of access, and to allow continuous monitoring of the sheath/catheter 
position and early recognition of complications. When introduced from a right axillary/subclavian 
vein or left internal jugular vein access, a long introducer sheath is favored to overcome the acute 
angle of access to the superior vena cava. It is important to emphasize that when a superior 
approach is undertaken, catheter manipulation will be reversed compared to an inferior venous 
access. Therefore, once the ICE transducer is positioned in the “home view” facing the tricuspid 
annulus, counterclockwise (instead of clockwise) rotation applied to the catheter will bring into 
view sequentially: the anterior LA; the mitral valve and left atrial appendage (LAA); the left 
pulmonary veins (PVs); the posterior LA wall; and the right PVs. 
 One of the principle advantages of ICE-assisted transseptal access is the ability to 
determine the optimal site of puncture along the interatrial septum. In this regard, while the 
posterior-inferior portion of the fossa ovalis with far-field visualization of the left PVs is typically 












considered the ideal site of access for AF ablation procedures from a standard inferior venous 
approach, the use of this access point from a superior approach renders mapping and ablation of 
the septal segments of the right PVs (particularly of the right inferior PV) more challenging. In our 
experience, obtaining access through the more superior (i.e., superior half) and anterior portion of 
the fossa ovalis, defined by ICE as the plane of the fossa ovalis with far-field visualization of the 
LAA (Figure 3 and Video 1), significantly improves mapping and ablation of the septal segments 
of the right PVs with minimal risk of losing transseptal access. Once access is accomplished, ICE 
is valuable to define the position of the mapping/ablation catheter and its relationship with the 
sheath, minimizing the need for fluoroscopy, and to screen for potential periprocedural 
complications. Transesophageal echo (TEE) is a potential alternative to ICE to guide transseptal 
access from a superior approach. However, the use of TEE, although possible, may be 
cumbersome as it would require a separate operator and echocardiography machine at the head 
of the operating table. 
Transseptal Access Technique 
 Although there are reports of successful transseptal catheterization from a superior 
approach using fixed-curve sheaths and a manually bent Brockenbrough transseptal needle,13 
this technique is highly dependent on the individual patient anatomy and ability to engage the 
fossa ovalis with non-steerable sheaths and standard transseptal needles. Furthermore, 
advancement of the transseptal dilator and sheath into the LA over a standard needle may be 
difficult. Our approach to transseptal catheterization from a superior access relies on the use of 
steerable sheaths (40cm Agilis EPITM, Abbott Laboratories, Chicago, IL; or 45cm SupraCross®; 
Baylis Medical) to engage the fossa ovalis, as validated by ICE imaging, and on the use of 
dedicated radiofrequency (RF) access wires (SupraCross® RF Wire; Baylis Medical) for 
puncture. 
 Because the body of the steerable sheath is significantly stiffer than standard non-
steerable sheaths, it is particularly difficult to maintain the curvature of a manually bent 
Brockenbrough needle once advanced within the sheath. In fact, during our early experience, we 
simulated advancement of a manually bent Brockenbrough needle within a deflectable sheath 












outside the body, and we were unable to maintain the preformed curvature of the needle within 
the sheath. This would have resulted in dislodgement of the sheath apparatus away from the 
transseptal site selected for puncture. 
 The choice of the steerable sheath is dependent on the individual patient anatomy. The 
SupraCross® sheath is a unidirectional deflectable sheath with a larger curve, a more flexible 
dilator, and a smoother transition between dilator and sheath compared to the Agilis EPITM 
sheath; these features enhance the steerability of the sheath with the dilator in place, facilitate the 
engagement and tenting of the fossa ovalis from a superior approach, and improve tracking of the 
sheath over the dilator into the LA. Once transseptal access is obtained, catheter manipulation for 
mapping and ablation can be easier with the Agilis EPITM sheath, due to its tighter deflection 
curve and bidirectional steerability. 
Figures 2 and 4 provide a step-by-step illustration of the approach used for transseptal 
catheterization from a superior access with sequential fluoroscopic images. First, the steerable 
sheath is advanced over a long J-tipped wire to the floor of the RA, close to the ostium of the 
coronary sinus (Figure 4A). At this point, the wire is removed and the dilator is pulled back inside 
the sheath, exposing only its distal portion (Figure 4B). This maneuver is important for two 
reasons: firstly, the sheath’s steerability is enhanced if the dilator is not fully exposed and 
secondly, this allows the dilator to track over the RF wire once access has been obtained while 
maintaining the sheath in contact with the interatrial septum. This latter aspect underpins a key 
technical difference compared to a standard transseptal access from an inferior venous 
approach. For instance, once the fossa ovalis has been properly engaged from an inferior venous 
approach, advancement of the entire sheath/dilator apparatus forward will result in a right-to-left 
movement of the transseptal apparatus, which will facilitate passage into the LA. When the fossa 
ovalis is engaged from a superior access with the sheath deflected with a more perpendicular 
angle (often close to 90 degrees, Figure 4B), any forward advancement of the sheath/dilator 
apparatus will result in a superior-to-inferior (rather than right-to-left) movement along the fossa 
ovalis, with subsequent loss of position. Therefore, once the fossa ovalis has been punctured, a 
right-to-left movement of the dilator may be produced only by keeping the sheath deflected and in 












contact with the fossa ovalis and gently re-exposing the dilator by pushing it forward to track over 
the wire into the LA. 
 The puncture is performed with a specialized pigtail RF wire (SupraCross® RF Wire; 
Baylis Medical), which is an insulated extra-stiff 0.035-inch wire with a flexible atraumatic distal 
spiral tip. The distal end of the wire contains exposed metal which allows for delivery of a short 
burst of RF energy (up to 15 Watts for up to 2 seconds) to enable puncture. The use of the 
SupraCross® RF wire has greatly simplified the puncture technique as it has eliminated the need 
for wire exchanges following the access to allow crossing of the dilator/sheath apparatus into the 
LA and tracking within the chamber. Indeed, for our initial cases (i.e., prior to commercial 
availability of the SupraCross® RF wire), we performed transseptal puncture with a straight 
endovascular RF wire (PowerWireTM, Baylis Medical) followed by exchange with a stiff pigtail wire 
(ProTrackTM, Baylis Medical, or TorayGuideTM wire, Toray Medical) to permit advancement of the 
sheath over the dilator.14 Once the sheath/dilator is in contact with the fossa ovalis, the tip of the 
SupraCross® wire is exposed outside of the dilator and a short pulse of RF energy is delivered to 
puncture the septum (Figure 4C). Direct visualization with ICE of fine echogenic “bubbles” within 
the LA generated by the RF application confirms LA entry (Video 2). 
 The wire is then advanced into the LA under fluoroscopic and ICE guidance until the full 
spiral end is deployed free (Figure 4D-E and Videos 3 and 4). At this point, the dilator is 
advanced within the LA over the wire using the aforementioned technique, and the sheath is 
subsequently advanced over the dilator to complete LA access (Figure 4F). If the operator 
encounters difficulty with tracking the sheath over the dilator, it is advisable to redirect the wire 
anteriorly toward the mitral annulus to obtain a more co-axial angle of access to the LA. 
Occasionally, we have advanced the SupraCross® wire into the left ventricle to achieve 
transseptal access from a superior approach; as mentioned earlier, the atraumatic curled distal 
end allows for advancement of the wire against the LA or ventricular wall without concern for risk 
of perforation. 
Another possible approach is the use of a SafeSept™ transseptal guidewire (Pressure 
Products, San Pedro, CA) which can be introduced through a standard Brockenbrough 












transseptal needle while tenting the fossa, the wire assumes a J shape after it pierces the fossa 
thus allowing for advancement within the LA with minimal risk for perforation. We have never 
used the SafeSept™ wire for superior access, but we would anticipate challenges in the 
advancement of the transseptal dilator and sheath within the left atrium over the SafeSept™ wire, 
as the body of the wire may not be stiff enough and provide adequate support. 
How to Perform Atrial Fibrillation Ablation from a Superior Approach 
 Although a dual transseptal access to the LA using the technique described above is 
feasible, for simplicity, we have performed most of our superior approach AF ablation cases with 
a single transseptal access and exchanging the multipolar mapping and ablation catheters 
through the same transseptal sheath (Figure 5). For mapping, we prefer to use multipolar 
catheters that can be safely manipulated within close proximity of the mitral annulus (e.g., 
Pentaray® catheter, Biosense Webster, Figure 5A) or even introduced into the left ventricle if 
needed. In this regard, if during the procedure, the sheath is inadvertently pulled back into the RA 
with the mapping catheter still within the LA, re-advancement of the sheath over the catheter into 
the LA is not difficult if a coaxial angle of access is maintained by deployment of the catheter 
toward the lateral mitral annulus or within the left ventricle, similar to the situation discussed prior 
with the SupraCross® wire. With respect to the ablation catheter, we have preferred the use of 
catheters with contact force-sensing technologies to enhance safety of mapping and ablation 
within the LA, particularly at the LA roof and superior PVs (see further below). Contact force-
sensing further allows validation of stable contact at specific regions of the LA, such as the 
anterior and inferior segments of the right PVs, as the approach to reach these regions from a 
superior access may require the use of combined sheath and catheter loops with tight deflections, 
resulting in minimal to complete lack of tactile feedback to the operator. 
 It is important to realize that the angle of sheath entry into the LA from a superior access 
differs to what is typically encountered with a conventional inferior venous approach. In order to 
minimize the risk of losing transseptal access, the deflectable sheath is usually directed toward 
the center of the LA and then deflected superiorly to allow for mapping of the PVs and posterior 
LA. In general, the specific catheter movements necessary to cannulate the left and right PVs and 












to map various segments of the LA are reversed compared to the traditional inferior venous 
approach. For instance, any forward advancement of the sheath and catheter will produce a 
superior-to-inferior and posterior-to-anterior catheter movement within the LA and reduce contact 
with the superior regions of the LA and the posterior wall. On the other hand, whenever the 
catheter or sheath are pulled back, the operator should pay close attention to the contact with the 
posterior LA and roof regions, as very high contact forces can be easily attainable with minimal 
movements. In addition, clockwise rotation of the sheath and catheter will reach the anterior 
segments of the LA, whereas counterclockwise torque will access the posterior segments. 
 Mapping and ablation of the left PVs and right superior PV can usually be performed via 
a direct approach (Figure 6A-C), that is, by simply maintaining the sheath in the center of the LA 
with superior deflection, as aforementioned, and advancing the catheter to map and ablate 
different aspects of the PVs. The most challenging region for mapping and ablation is the septal 
segment of the right PVs. If the LA access is properly performed at the superior and anterior 
aspect of the fossa ovalis, a direct approach with the sheath slightly pulled back close to the 
access site while maintaining counterclockwise torque is typically sufficient to perform ablation of 
the anterior right PV roof and septum up to the anterior carina region. Ablation of the anterior 
segments of the right inferior PV below the region of the carina with a direct approach is generally 
not possible and is also associated with a significant risk of losing transseptal access. Therefore, 
we prefer to approach ablation of the anterior segments of the right inferior PV by creating a large 
catheter loop within the body of the LA and then deflecting the catheter anteriorly to achieve 
contact with the septum. The loop is formed by directing the sheath toward the infero-lateral mitral 
annulus and maximally deflecting it to point backwards towards the septum. The catheter is then 
advanced and deflected anteriorly (Figure 7A). In patients with larger LA sizes, reaching the most 
inferior portions of the septum may be challenging even after creating a loop with the deflectable 
sheath; in these cases, forming a secondary loop with the catheter (Figure 7B) is usually 
adequate to achieve stable contact with the inferior septum and complete the ablation. 
 
 













 We describe our technique to perform LA transseptal catheterization and AF ablation via 
a superior venous access under ICE guidance, using steerable sheaths and dedicated RF wires. 
This approach has permitted catheter ablation of AF in patients with IVC-I in whom a standard 
procedure from a transfemoral venous approach is not feasible. 
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Figure 1. Example of procedure room setup during a left axillary vein access (Panels A and B) 
and right internal jugular vein access (Panels C and D) AF ablation. Panel A: Left axillary vein 
access is used for the transseptal sheath and ICE catheter. Panel B: To improve ergonomics a 
second table is positioned at the side of the patient’s table to facilitate manipulation of the 
deflectable sheath and ablation catheter and maintain a coaxial angle of access to the axillary 
vein. Panel C: Right internal jugular vein access is used for the transseptal sheath and a separate 
right axillary vein access is used for the ICE catheter and the diagnostic coronary sinus catheter. 
Panel D: Manipulation of the deflectable sheath and mapping/ablation catheter from a right 
internal jugular vein approach is less favorable compared to a left axillary vein approach. The 
operator stands at the head of the table while holding the deflectable sheath and catheter in place 

























Figure 2. Schematic illustrating the technique for left atrial access from a superior approach 
(axillary vein). The deflectable sheath is advanced to the right atrium and deflected to engage the 
fossa ovalis (Panel A). Once proper tenting of the fossa ovalis has been verified with intracardiac 
echo, the Supracross® wire is exposed and RF is applied to obtain access. The wire is advanced 
to the LA to deploy the full spiral (Panel B) and allow for the dilator and sheath to cross to the LA 
(Panel C). The specific anatomical relationships relevant to the transseptal access are similar to 
what typically encountered with a standard left atrial transseptal catheterization from a femoral 
venous approach. 
 
Figure 3. ICE image showing the sheath and dilator positioned at the superior and anterior 
aspect of the fossa ovalis to obtain LA transseptal access from a superior approach. MV = mitral 
valve; LAA = left atrial appendage; RA = right atrium; LA = left atrium; LV = left ventricle. 
 












Figure 4. Step-by-step illustration of the approach used for transseptal catheterization from a 
superior access. Panel A: the deflectable sheath is advanced to the floor of the RA over a long 
guidewire with the dilator fully exposed. Panel B: the wire is removed and the dilator is pulled 
back within the sheath. The sheath is then deflected to an almost 90-degree angle while applying 
counterclockwise rotation to facilitate engagement of the superior and anterior portion of the fossa 
ovalis. Panel C: once the fossa ovalis has been engaged, the tip of Supracross® RF wire is 
exposed to puncture the septum. Panel D: radiofrequency is applied to the tip of the Supracross® 
wire and the wire is advanced within the LA until the full wire spiral is deployed. Panels E-F: to 
facilitate advancement of the dilator and sheath in the LA, the wire is advanced to the mitral 
annulus to obtain a more coaxial angle of access to the LA. 
 


















Figure 6. Example of approach used to map and ablate the left pulmonary veins (Panels A and 
B) and the right superior pulmonary vein (Panel C). This can be usually accomplished via a direct 
approach by maintaining the sheath in the body of the LA and advancing the catheter to map and 
ablate different aspects of the PVs. 
 
Figure 7. Example of approach to map and ablate the anterior segments of the right inferior PV. 
Typically, this is best accomplished by creating a large loop with the sheath (Panel A) and/or 
catheter (Panel B). 
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